In light of the draft of a leaked majority Supreme Court decision to overturn Roe v Wade, I want to call your attention to the people that would be impacted most by the end of legalized abortion across the United States. 🧵:

California will not stand by as women across America are stripped of their rights. With Senator Toni Atkins and @Rendon63rd, we are proposing an amendment to enshrine the right to choose in the California constitution. #RoeVsWade

This sounds awesome! Check out Kavita K. Mishra, MD MPH Brieze Bell and the rest of this amazing list of educators in their @OsherMiniMed course for the public!

Check out this super cool undertaking by UC San Francisco UCSF IM Chiefs Dr. Jordyn Silverstein, MD (future oncologist extraordinaire), a podcast to explain #cancer to the public. ASCO Hem-Onc Fellows Network @OsherMiniMed

Studies suggest that while people are most likely to test positive on antigen tests during the first week of illness, a notable subset of people continue to test positive for 10 days or longer. nyti.ms/3M13BsA

Come check out some #MedEd projects at the ASCO poster session! Fun doing these projects with fellow ESP alum Tyler Johnson Stanford University, #workspouse shagun arora, and other amazing UC San Francisco UCSF School of Medicine UCSF Neuroscience UCSF Helen Diller Family Comprehensive Cancer Ctr colleagues! #OncMedEdCoP

Great BA.5 primer by Eric Topol. Key points: 1) Will be dominant variant soon 2) ⬆infectious & ⬆immune evasive vs prior variants 3) Severity unclear, but some ⬆hospitalizations 4) Adds to case for 2nd boost & masking 5) New bivalent vax may not add much erictopol.substack.com/p/the-ba5-story

FDA Grants Breakthrough Therapy Designation to Talquetamab for Relapsed/Refractory Myeloma onclive.com/view/fda-grant…

Teclistamab BCMA-CD3 targeted bispecific monoclonal antibody was just approved in Europe for the treatment of multiple myeloma. A huge step forward for individual patients and for the field overall! #mmsm International Myeloma Foundation Multiple Myeloma RF @healthtreeforMM Sylvester Comprehensive Cancer Center

Finished an advance copy of ⁦Siddhartha Mukherjee⁩ new book “The Song of the Cell” out 10/25. It’s another masterful work by this author; a sweeping treatise on the discovery of cell functions, how they sometimes go awry in disease, and can be manipulated to create new therapies

They finished 4-years of undergrad, 4-years of medical school, endured 3-7 years of residency (some going on to get other degrees!), work 50-90 hrs a week... and you still can't call female physicians "Doctor" when you email or send them a message? jamanetwork.com/journals/jaman…

Great UC San Francisco Medicine Grand Rounds on #LongCovid, w/ @LekshmiMD, Michael Peluso, MD, Zaid Al-Ali. I think folks are now recognizing risk of prolonged sxs, but haven't wrapped their heads around long-term risk of non-communicable diseases. It's real, & concerning. youtube.com/watch?v=YGAfCW…

Sarina Esmailzadeh, 16, beaten to death by Iranian security forces for protesting for women’s rights in Iran. Nika Shakarami, 16, killed after burning her headscarf in protest. Hadis Najafi, 23, shot multiple times during demonstrations sparked by the death of Mahsa Amini, 22,

A student interested in #oncology asked me: How to balance the excitement over oncologic diagnosis and treatment with the fact that cancer is devastating for people? A key question. Totally ok to nerd out (I do a lot), but don’t let intellectual enthusiasm overshadow compassion.

Incredibly important (and devastating) work by UC San Francisco third-year fellow @meera_ragavan and mentors on the impact of #cancer on financial security. UCSF Helen Diller Family Comprehensive Cancer Ctr Family Reach

This is disappointing. The NEJM 2022;387:468-470 article showed that of the FDA approved drugs, only bebtelovimab effectively neutralized the recent COVID strains. Now what? We need to return to the basics. Masking, hand washing, protecting our vulnerable. #CovidIsntOver

The most important trial at #ASH22: NEUTRODIET, a randomized multicenter trial of 'neutropenic diet' vs normal diet after auto/alloSCT. No differences in infections, aGHVD or hospital days between arms. Less weight loss & better patient satisfaction in normal diet arm! #tcellrx

Register now: "Institutional Perspectives in Cancer: Multiple Myeloma" January 26, 2023 OncLive.com WEBINAR with Tom Martin Tom Martin UCSF Health ow.ly/Vern50LHw8x

🧵 I would add that in addition to questionable (IMHO little to no) benefit the costs of MOC end up in the health care system. That money comes from somewhere, whether it is the pockets of physicians, patients or both. #EndMOC

Thank you Krishna Komanduri, MD, FASTCT and UCSF Health for the invitation to talk about the work my team is doing, and for your partnership on the MEASURE clinical protocol to prospectively validate Measurable Residual Disease (MRD) testing for patients with AML. Also managed to slide in the